Janux Therapeutics, Inc. (JANX) vs Teladoc Health, Inc. (TDOC)

A side-by-side comparison of Janux Therapeutics, Inc. and Teladoc Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — JANX vs TDOC

growth of $100 · dividends reinvested · last 5y
JANX -34.2% (-8.0%/yr)TDOC -96.2% (-48.1%/yr)JANX compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020222023202420252026$66$4
JANX TDOC

JANX vs TDOC: by the numbers

  • •TDOC is the larger company ($1.06B vs $998M market cap).
  • •Both run net losses; TDOC's is the smaller (-7.13% vs -321.81% net margin).
  • •JANX grew revenue faster over the past five years (105.89% vs 8.85% CAGR).

Metrics side by side

Valuation

MetricJANXTDOC
P/S ratio31.320.42
P/B ratio1.080.81
EV / EBITDAN/A12.97
FCF yieldN/A21.26%

Profitability

MetricJANXTDOC
Gross margin79.71%73.53%
Operating margin-1576.67%-6.98%
Net margin-321.81%-7.13%
ROE-11.06%-13.54%
ROIC-15.15%-7.32%

Growth (annualized)

MetricJANXTDOC
Revenue CAGR (5Y)105.89%8.85%
Total return CAGR (5Y)-6.45%-45.85%

Frequently asked

Which has grown faster, JANX or TDOC?
Over the past five years, JANX grew revenue faster — JANX at a 105.89% CAGR versus TDOC at 8.85%.
How have JANX and TDOC total returns compared?
Over the past 5 years, JANX delivered -6.45% and TDOC delivered -45.85% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.